New study tests tools to help families share cancer genetic results
NCT ID NCT04763915
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
The IMPACT Study is testing two online tools—GeneSHARE and LivingLabReport—to help people with inherited cancer gene variants share their results with family members and follow cancer screening guidelines. The study involves 720 adults who have a genetic variant linked to cancers like breast, prostate, or colorectal cancer. Researchers will measure whether these tools improve family communication and guideline-based care over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GeneSHARE web-based toolkit and LivingLabReport website
What this could lead to
If successful, this could lead to better ways for people with inherited cancer risks to communicate with family and follow recommended screenings.
What could go wrong
This is a behavioral study, not a drug trial, so it won't directly treat or cure cancer. Results depend on participants' willingness to use the tools and share information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37212, United States